Sports
Breast Cancer HER2 Subtype Identification
Predicting HER2 Status Using Histopathological Images.
Predicting HER2 Status Using Histopathological Images.

Breast cancer is a major cause of mortality among women, with HER2-positive cases being particularly aggressive. Identifying HER2 status early and accurately is essential to improving treatment outcomes. However, the conventional FISH test, widely used for this purpose, is labor-intensive, time-consuming, and requires highly trained professionals.
The Dow University of Health Sciences (DUHS), one of Pakistan's oldest public universities, has been a leader in health sciences since 1945. Renowned for its focus on biomedical, health, and medical research, DUHS encompasses esteemed institutions like Dow International Medical College and Dow Medical College. The university offers a comprehensive range of undergraduate, postgraduate, and doctoral programs and has a strong postgraduate department overseeing medical sciences research.
DUHS faced challenges with the traditional FISH testing method, as it is both time-consuming and dependent on specialized expertise, which can limit the speed and accessibility of HER2 testing. Given the high mortality rate associated with HER2-positive breast cancer, the university needed an efficient, accurate, and scalable solution to streamline HER2 testing.
Folio3 AI in partnership with Fidel AI, developed an AI-powered system automating HER2 testing for faster, accurate diagnosis.
Thanks to this AI-powered solution, DUHS has achieved significant improvements in both the efficiency and precision of HER2 testing. Practitioners can now perform the test faster and with greater accuracy, storing digitized images for easy access and future analysis.



Machine Learning Based Completion Estimation

Govzilla provides a platform that leverages AI and big data

https://aiml-staging.folio3.site/admin/collections/pages